Acasti Pharma, a subsidiary of Neptune Technologies & Bioressources, announced the recruitment of Reed V. Tuckson, M.D. to its Board of Directors. Dr. Tuckson’s appointment will increase Acasti’s Board member total to 6, 4 of which are currently independent directors.
“Dr. Tuckson is a recognized leader in his field,” commented President and CEO of Acasti, Henri Harland. “He brings a strong reputation, deep industry knowledge and valuable insight into health and medical care, including the translation of science and technology into clinical interventions. We look forward to his leadership in supporting and communicating our science-based research and drug development activities on omega-3 phospholipids.”
“Throughout my career, whether as Commissioner of Public Health for the District of Columbia, as Chief of Medical Affairs for the largest health insurer in the United States, or as Managing Director of Tuckson Health Connections, I have always sought to bring the most effective health solutions to the greatest possible number of people,” stated Dr. Tuckson. “The differentiated benefits of omega-3 phospholipids for pharmaceutical applications are becoming better understood and I am excited about the opportunities ahead for Acasti and its prescription drug candidate, CaPre®. I believe that CaPre® has the potential to make a real difference in cardiovascular care for people worldwide. I look forward to joining Acasti’s Board and supporting and communicating the developments that continue to be key to the Corporation’s continued success.”
Dr. Tuckson currently sits as the Managing Director of Tuckson Health Connections, LLC, a health and medical care consulting firm. Prior to that, he served in the position of Executive Vice President and Chief of Medical Affairs for UnitedHealth Group, a Fortune 25 health and wellbeing company, which includes the industry’s most comprehensive health services company and the United States largest health insurer.
In addition, Dr. Tuckson is a member of the Advisory Committee to the Director of the National Institutes of Health and is also an active member of the Institute of Medicine of the National Academy of Sciences. He also sits on the Boards of Howard University, American Telemedicine Association, and Cell Therapeutics Inc., a public company. Dr. Tuckson has been noted a number of times by Modern Healthcare Magazine as one of the “50 Most Powerful Physician Executives” in healthcare and in addition, Black Enterprise Magazine named him as one of the “Most Powerful Executives in Corporate America.”
Dr. Tuckson is a graduate of Georgetown University School of Medicine, Howard University, and the Hospital of the University of Pennsylvania’s General Internal Medicine Residency and Fellowship Programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.
To learn more, please visit www.acastipharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
